Global Life Science Ventures — Investing in the life sciences

Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than € 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.

Profile
Experience
History
Clear Focus
Key Strengths
Track Record
Expert Group
Team
Investment Practice
Portfolio
FAQ
Download Area
News
Events
Contact Us
Text size

Sir John James Skehel - biography

Sir John James Skehel is the Director of the MRC National Institute for Medical Research in London. He has been a member of the Medical Research Council scientific staff since 1971. He was director of the WHO Collaborating Centre for Reference and Research on Influenza from 1975 to 1994 and is currently Head of the Infections and Immunity Group. Among others he has received the Robert Koch Prize, the Louis Jeantet Prix de Medicine and the ICN International Prize in Virology. Sir John is a member of several scientific advisory boards and author of numerous scientific publications.

< back